GlaxoSmithKline shareholders approve sale of £1.18 billion healthcare assets
Cairo – Mubasher: The Extraordinary General Assembly of GlaxoSmithKline approved, by 99.99% of the votes of the attending shareholders after excluding the main shareholder’s vote, the sale of movable consumer healthcare assets (not including real estate and machinery) and intangible assets. The company added, in a statement to the Egyptian Stock Exchange, today: “It is … Read more